Physician profile
Ashley Han
NPI 1073047213
$506.54
in general payments reported to CMS, 2019-2025
11 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $159 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $171.60 | 2024-2025 | |
| Philips North America LLC | $62.28 | 2025 | Encore |
| Glaxosmithkline, LLC. | $45.81 | 2025 | Nucala |
| Biocryst US Sales Co., LLC | $41.22 | 2025 | Orladeyo |
| Astrazeneca Pharmaceuticals LP | $31.22 | 2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $31.12 | 2024 | Takhzyro |
| Alk-Abello, INC | $29.97 | 2025 | Grastek, Odactra, Ragwitek |
| Cycle Pharmaceuticals INC | $26.10 | 2025 | Sajazir |
| Regeneron Healthcare Solutions, INC. | $22.70 | 2024 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $22.26 | 2025 | Neffy |
| Vertex Pharmaceuticals Incorporated | $22.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.